Alicia Staley on Making Clinical Trials More Accessible
Alicia Staley on the importance of making clinical trials accessible for patients.
Liso-Cel Elicits Rapid, Durable Responses in Relapsed/Refractory CLL/SLL
Adding Azoles May Not Impact Efficacy of Ruxolitinib in Acute GVHD Treatment
Ruxolitinib Plus Belumosudil Confers a 55% Response Rate in GVHD
Ruxolitinib Cream Improves Body Surface Area in Cutaneous GVHD
2 Commerce Drive Cranbury, NJ 08512